MEDX.SW

HoldSecond Wind

medmix AG · Industrials · Switzerland · $491M cap · $967K/day traded

CHF 9.93 +1.1% · close 14 Oct · scored 16 Oct

Second Wind: Cheap and rising again, but the business does not yet earn the optimism.

53
StockRank
Get score and insider alerts
Quality
38
Value
55
Momentum
53

As of 16 Oct 2026, MoatMap's StockRank for medmix AG (MEDX.SW) is 53/100, ranked against 24,000+ stocks in 35 markets (Quality 38, Value 55, Momentum 53, each scored against its sector).

Does StockRank work? Each month we publish how every decile did, whichever way it went. See the record →

P/E (TTM)
—
peers 25.7x
ROE
0.2%
peers 12.6%
D/E
0.7x
peers 0.4x
Dividend %
1.0%
trailing yield
Loading 1Y...
PRICE (1Y) · CHF+10.5%
8.69.09.49.810.13 Sep24 Sep14 Oct
SMA 50SMA 200

Price checkTurning upExperimental

30% above its 52-week low and back above a rising 50-day average since 21 Sep 2026.

SwingsAverage

Calmer than 70% of stocks we rank over the past year (31% a year).

How this is worked out

StockRank judges the business. The price check reads only the chart: it is the price side of the Momentum score, in words.

The rules: Still falling is a new 52-week low in the last two weeks, at least 25% below the high. Finding a floor is no new low since. Turning up is 20 or more trading days without a new low, at least 10% off it, and back above a rising 50-day average. In an uptrend is above the 200-day average and within 15% of the high.

In 2,112 US drawdowns since 2001, buying while the price was still falling was followed by a further 20% drop 42% of the time. Waiting for a turn like this one cut that to 33%, at about 7% higher prices and with no better returns. Part of that cut is simply not buying: 13% of falls never turned, and waiting kept those out. Among turns that were bought, 38% still fell another 20%, and 33% of turns were followed by a new low within six months. The benefit was largest in crashes such as 2008 and 2020.

What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.

What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.

Calm is not safe: a calm stock can still slide steadily.

Rules fixed before any data was fetched. Describes the chart, not a recommendation.

Close
CHF 9.93
RSI (14)
52.5
52-Week Range-18.8% from high
Low CHF 7.61High CHF 12.22

SCORE BREAKDOWN

Quality
38
ROIC
2.5%19.5
ROE
0.2%17.9
GP/Assets
16.8%49.2
Op. Margin
7.7%50.6
FCF/Assets
2.8%48.2
Piotroski
365.7
Int. Cover
1.8x20.6
D/E Ratio
0.74x28.6
Current Ratio
1.52x41.9
Value
55
P/E (TTM)
—N/A
EV/EBITDA
8.6x66.5
P/FCF
15.3x59.9
P/B
0.9x79.0
P/S
0.9x64.7
Div Yield
1.0%29.8
Momentum
53
52W High %
81%65.2
RS 6M
4%70.2
SMA 50/200
0.99x52.0
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
-93%1.1

FUNDAMENTALS

Market Cap
$491M
P/E (Forward)
17.5x
Gross Margin
36.7%

SECTOR PEERS

Closest peers in Industrials, ranked by industry match, size, and score similarity. Cross-listings of MEDX.SW are excluded.

TickerCompanyMkt CapStockRankSignal
MEDX.SWmedmix AG(you)$491M53Hold
KOMN.SWKomax Holding AG$473M69Buy
MTG.SWMeier Tobler Group AG$449M74Buy
INRN.SWInterroll Holding AG$1.5B57Hold
KARN.SWKardex Holding AG$2.3B54Hold
MIKN.SWMikron Holding AG$330M81Strong Buy
BYS.SWBystronic AG$323M22Sell
PMN.SWPhoenix Mecano AG$495M95Strong Buy
OERL.SWOC Oerlikon Corporation AG$2.3B66Buy
FTON.SWFeintool International Holding AG$218M85Strong Buy

Peer medians: ROE 12.6% · P/E 25.7x · Gross margin 49.2%

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

medmix AG (MEDX.SW): Stock Score Summary

medmix AG (MEDX.SW) has a MoatMap StockRank of 53/100 based on Quality (38/100), Value (55/100), and Momentum (53/100) factor scores. The current signal is HOLD.

Key Financial Metrics

PriceCHF 9.93
Market Cap$491M
P/E (Forward)17.53
Price/Book0.94
Return on Equity0.2%
Return on Invested Capital2.5%
Debt/Equity0.74x
Gross Margin36.7%
Operating Margin7.7%
Revenue Growth-4.9%
Dividend Yield1.0%
Free Cash Flow$32M

medmix AG operates in the Specialty Industrial Machinery industry, part of the Industrials sector (Switzerland).

Frequently Asked Questions

What is medmix AG’s (MEDX.SW) StockRank?
MoatMap’s StockRank for medmix AG (MEDX.SW) is 53/100, with a Hold signal. It is a composite of Quality (38), Value (55), and Momentum (53), each scored against its sector. The composite is then ranked across MoatMap’s universe of 24,000+ stocks.
Does medmix AG have an economic moat?
medmix AG (MEDX.SW) has a Quality factor score of 38/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is medmix AG a buy, hold, or sell?
MoatMap’s current signal for medmix AG (MEDX.SW) is Hold, based on a StockRank of 53/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is medmix AG in?
medmix AG (MEDX.SW) operates in the Industrials sector, specifically the Specialty Industrial Machinery industry (Switzerland).